ExodusPoint Capital Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-236,724
Closed -$3.47M 1487
2025
Q3
$3.47M Sell
236,724
-72,297
-23% -$1.24M 0.05% 537
2025
Q2
$5.63M Buy
+309,021
New +$6.3M 0.07% 398
2025
Q1
Sell
-102,351
Closed -$1.75M 1404
2024
Q4
$1.75M Buy
+102,351
New +$1.93M 0.02% 763
2024
Q1
Sell
-303,596
Closed -$1.37M 1450
2023
Q4
$1.37M Sell
303,596
-99,121
-25% -$367K 0.02% 696
2023
Q3
$1.44M Buy
402,717
+76,948
+24% +$296K 0.02% 812
2023
Q2
$1.2M Buy
+325,769
New +$1.21M 0.01% 1031
2023
Q1
Sell
-35,632
Closed -$138K 1706
2022
Q4
$138K Sell
35,632
-15,857
-31% -$48.9K ﹤0.01% 1495
2022
Q3
$125K Sell
51,489
-15,109
-23% -$36.2K ﹤0.01% 1717
2022
Q2
$132K Sell
66,598
-636,553
-91% -$1.25M ﹤0.01% 1713
2022
Q1
$1.29M Buy
703,151
+680,953
+3,068% +$1.06M 0.02% 997
2021
Q4
$31K Sell
22,198
-12,499
-36% -$16.4K ﹤0.01% 2064
2021
Q3
$39K Buy
+34,697
New +$48.6K ﹤0.01% 1988
2021
Q2
Sell
-92,360
Closed -$163K 2280
2021
Q1
$163K Sell
92,360
-5,296
-5% -$12.1K ﹤0.01% 1908
2020
Q4
$190K Buy
+97,656
New +$205K ﹤0.01% 1747
2020
Q3
Sell
-68,050
Closed -$199K 1693
2020
Q2
$199K Sell
68,050
-35,163
-34% -$101K 0.01% 1520
2020
Q1
$297K Buy
+103,213
New +$357K 0.03% 654
2019
Q2
Sell
-15,482
Closed -$59K 1063
2019
Q1
$59K Buy
+15,482
New +$54.7K 0.01% 633

Other funds holding ADMA